Wang S, Li H S, Qian W, Zhang X R, He W F, Luo G X
State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burn Research, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing Key Laboratory for Wound Repair and Regeneration, Chongqing 400038, China Department of Burns and Plastic Surgery, General Hospital of Central Theater Command of People's Liberation Army, Wuhan 430064, China.
State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burn Research, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing Key Laboratory for Wound Repair and Regeneration, Chongqing 400038, China.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Feb 20;38(2):119-129. doi: 10.3760/cma.j.cn501120-20211210-00410.
To explore the effects of P311 on the angiogenesis ability of human microvascular endothelial cell 1 (HMEC-1) in vitro and the potential molecular mechanism. The experimental research method was used. HMEC-1 was collected and divided into P311 adenovirus group and empty adenovirus group according to the random number table (the same grouping method below), which were transfected correspondingly for 48 h. The cell proliferation activity was detected using the cell counting kit 8 on 1, 3, and 5 days of culture. The residual scratch area of cells at post scratch hour 6 and 11 was detected by scratch test, and the percentage of the residual scratch area was calculated. The blood vessel formation of cells at 8 h of culture was observed by angiogenesis experiment in vitro, and the number of nodes and total length of the tubular structure were measured. The protein expressions of vascular endothelial growth factor receptor 2 (VEGFR2), phosphorylated VEGFR2 (p-VEGFR2), extracellular signal-regulated kinase 1/2 (ERK1/2), and phosphorylated ERK1/2 (p-ERK1/2) in cells were detected by Western blotting. HMEC-1 was collected and divided into P311 adenovirus+small interfering RNA (siRNA) negative control group, empty adenovirus+siRNA negative control group, P311 adenovirus+siRNA-VEGFR2 group, and empty adenovirus+siRNA-VEGFG2 group, which were treated correspondingly. The protein expressions of VEGFR2, p-VEGFR2, ERK1/2, and p-ERK1/2 in cells were detected by Western blotting at 24 h of transfection. The blood vessel formation of cells at 24 h of transfection was observed by angiogenesis experiment in vitro, and the number of nodes and total length of the tubular structure were measured. HMEC-1 was collected and divided into P311 adenovirus+dimethylsulfoxide (DMSO) group, empty adenovirus+DMSO group, P311 adenovirus+ERK1/2 inhibitor group, and empty adenovirus+ERK1/2 inhibitor group, which were treated correspondingly. The protein expressions of ERK1/2 and p-ERK1/2 in cells were detected by Western blotting at 2 h of treatment. The blood vessel formation of cells at 2 h of treatment was observed by angiogenesis experiment in vitro, and the number of nodes and total length of the tubular structure were measured. The sample number at each time point in each group was 6. Data were statistically analyzed with independent sample test, analysis of variance for repeated measurement, one-way analysis of variance, and least significant difference test. Compared with that of empty adenovirus group, the proliferation activity of cells in P311 adenovirus group did not show significant difference on 1, 3, and 5 days of culture (with values of -0.23, -1.30, and -1.52, respectively, >0.05). The residual scratch area percentages of cells in P311 adenovirus group were significantly reduced at post scratch hour 6 and 11 compared with those of empty adenovirus group (with values of -2.47 and -2.62, respectively, <0.05). At 8 h of culture, compared with those of empty adenovirus group, the number of nodes and total length of the tubular structure of cells in P311 adenovirus group were significantly increased (with values of 4.49 and 4.78, respectively, <0.01). At 48 h of transfection, compared with those of empty adenovirus group, the protein expressions of VEGFR2 and ERK1/2 of cells in P311 adenovirus group showed no obvious changes (>0.05), and the protein expressions of p-VEGFR2 and p-ERK1/2 of cells in P311 adenovirus group were significantly increased (with values of 17.27 and 16.08, <0.01). At 24 h of transfection, the protein expressions of p-VEGFR2 and p-ERK1/2 of cells in P311 adenovirus+siRNA negative control group were significantly higher than those in empty adenovirus+siRNA negative control group (<0.01). The protein expressions of VEGFR2, p-VEGFR2, and p-ERK1/2 of cells in P311 adenovirus+siRNA negative control group were significantly higher than those in P311 adenovirus+siRNA-VEGFR2 group (<0.01). The protein expressions of VEGFR2 and p-ERK1/2 of cells in empty adenovirus+siRNA negative control group were significantly higher than those in empty adenovirus+siRNA-VEGFR2 group (<0.05 or <0.01). At 24 h of transfection, the number of nodes of the tubular structure in cells of P311 adenovirus+siRNA negative control group was 720±62, which was significantly more than 428±38 in empty adenovirus+siRNA negative control group and 364±57 in P311 adenovirus+siRNA-VEGFR2 group (with values both <0.01). The total length of the tubular structure of cells in P311 adenovirus+siRNA negative control group was (21 241±1 139) μm, which was significantly longer than (17 005±1 156) μm in empty adenovirus+siRNA negative control group and (13 494±2 465) μm in P311 adenovirus+siRNA-VEGFR2 group (with values both <0.01). The number of nodes of the tubular structure in cells of empty adenovirus+siRNA negative control group was significantly more than 310±75 in empty adenovirus+siRNA-VEGFR2 group (<0.01), and the total length of the tubular structure of cells in empty adenovirus+siRNA negative control group was significantly longer than (11 600±2 776) μm in empty adenovirus+siRNA-VEGFR2 group (<0.01). At 2 h of treatment, the protein expression of p-ERK1/2 of cells in P311 adenovirus+DMSO group was significantly higher than that in empty adenovirus+DMSO group and P311 adenovirus+ERK1/2 inhibitor group (with values both <0.01), and the protein expression of p-ERK1/2 of cells in empty adenovirus+DMSO group was significantly higher than that in empty adenovirus+ERK1/2 inhibitor group (<0.05). At 2 h of treatment, the number of nodes of the tubular structure in cells of P311 adenovirus+DMSO group was 726±72, which was significantly more than 421±39 in empty adenovirus+DMSO group and 365±41 in P311 adenovirus+ERK1/2 inhibitor group (with values both <0.01). The total length of the tubular structure of cells in P311 adenovirus+DMSO group was (20 318±1 433) μm, which was significantly longer than (16 846±1 464) μm in empty adenovirus+DMSO group and (15 114±1 950) μm in P311 adenovirus+ERK1/2 inhibitor group (with values both <0.01). The number of nodes of the tubular structure in cells of empty adenovirus+DMSO group was significantly more than 317±67 in empty adenovirus+ERK1/2 inhibitor group (<0.01), and the total length of the tubular structure of cells in empty adenovirus+DMSO group was significantly longer than (13 188±2 306) μm in empty adenovirus+ERK1/2 inhibitor group (<0.01). P311 can enhance the angiogenesis ability of HMEC-1 by activating the VEGFR2/ERK1/2 signaling pathway.
探讨P311对人微血管内皮细胞1(HMEC-1)体外血管生成能力的影响及其潜在分子机制。采用实验研究方法。收集HMEC-1,按随机数字表法分为P311腺病毒组和空腺病毒组(以下分组方法相同),分别进行相应转染48小时。在培养的第1、3和5天,使用细胞计数试剂盒8检测细胞增殖活性。通过划痕试验检测划痕后6小时和11小时细胞的残余划痕面积,并计算残余划痕面积百分比。通过体外血管生成实验观察培养8小时时细胞的血管形成情况,并测量节点数和管状结构的总长度。采用蛋白质印迹法检测细胞中血管内皮生长因子受体2(VEGFR2)、磷酸化VEGFR2(p-VEGFR2)、细胞外信号调节激酶1/2(ERK1/2)和磷酸化ERK1/2(p-ERK1/2)的蛋白表达。收集HMEC-1,分为P311腺病毒+小干扰RNA(siRNA)阴性对照组、空腺病毒+siRNA阴性对照组、P311腺病毒+siRNA-VEGFR2组和空腺病毒+siRNA-VEGFG2组,分别进行相应处理。在转染24小时时,采用蛋白质印迹法检测细胞中VEGFR2、p-VEGFR2、ERK1/2和p-ERK1/2的蛋白表达。通过体外血管生成实验观察转染24小时时细胞的血管形成情况,并测量节点数和管状结构的总长度。收集HMEC-1,分为P311腺病毒+二甲基亚砜(DMSO)组、空腺病毒+DMSO组、P311腺病毒+ERK1/2抑制剂组和空腺病毒+ERK1/2抑制剂组,分别进行相应处理。在处理2小时时,采用蛋白质印迹法检测细胞中ERK1/2和p-ERK1/2的蛋白表达。通过体外血管生成实验观察处理2小时时细胞的血管形成情况,并测量节点数和管状结构的总长度。每组各时间点样本数为6。数据采用独立样本t检验、重复测量方差分析、单因素方差分析和最小显著差异检验进行统计学分析。与空腺病毒组相比,P311腺病毒组细胞在培养第1、3和5天的增殖活性无显著差异(t值分别为-0.23、-1.30和-1.52,均>0.05)。与空腺病毒组相比,P311腺病毒组细胞在划痕后6小时和11小时的残余划痕面积百分比显著降低(t值分别为-2.47和-2.62,均<0.05)。在培养8小时时,与空腺病毒组相比,P311腺病毒组细胞的管状结构节点数和总长度显著增加(t值分别为4.49和4.78,均<0.01)。在转染48小时时,与空腺病毒组相比,P311腺病毒组细胞中VEGFR2和ERK1/2的蛋白表达无明显变化(均>0.05),而P311腺病毒组细胞中p-VEGFR2和p-ERK1/2的蛋白表达显著增加(t值分别为17.27和16.08,均<0.01)。在转染24小时时,P311腺病毒+siRNA阴性对照组细胞中p-VEGFR2和p-ERK1/2的蛋白表达显著高于空腺病毒+siRNA阴性对照组(均<0.01)。P311腺病毒+siRNA阴性对照组细胞中VEGFR2、p-VEGFR2和p-ERK1/2的蛋白表达显著高于P311腺病毒+siRNA-VEGFR2组(均<0.01)。空腺病毒+siRNA阴性对照组细胞中VEGFR2和p-ERK1/2的蛋白表达显著高于空腺病毒+siRNA-VEGFR2组(<0.05或<0.01)。在转染24小时时,P311腺病毒+siRNA阴性对照组细胞的管状结构节点数为720±62,显著多于空腺病毒+siRNA阴性对照组的428±38和P311腺病毒+siRNA-VEGFR2组的364±57(t值均<0.01)。P311腺病毒+siRNA阴性对照组细胞的管状结构总长度为(21 241±1 139)μm,显著长于空腺病毒+siRNA阴性对照组的(17 005±1 156)μm和P311腺病毒+siRNA-VEGFR2组的(13 494±2 465)μm(t值均<0.01)。空腺病毒+siRNA阴性对照组细胞的管状结构节点数显著多于空腺病毒+siRNA-VEGFR2组的310±75(<0.01),空腺病毒+siRNA阴性对照组细胞的管状结构总长度显著长于空腺病毒+siRNA-VEGFR2组的(11 600±2 776)μm(<0.01)。在处理2小时时,P311腺病毒+DMSO组细胞中p-ERK1/2的蛋白表达显著高于空腺病毒+DMSO组和P311腺病毒+ERK1/2抑制剂组(t值均<0.01),空腺病毒+DMSO组细胞中p-ERK1/2的蛋白表达显著高于空腺病毒+ERK1/2抑制剂组(<0.05)。在处理2小时时,P311腺病毒+DMSO组细胞的管状结构节点数为726±72,显著多于空腺病毒+DMSO组的421±39和P311腺病毒+ERK1/2抑制剂组的365±41(t值均<0.01)。P311腺病毒+DMSO组细胞的管状结构总长度为(20 318±1 433)μm显著长于空腺病毒+DMSO组的(16 846±1 464)μm和P311腺病毒+ERK1/2抑制剂组的(15 114±1 950)μm(t值均<0.01)。空腺病毒+DMSO组细胞的管状结构节点数显著多于空腺病毒+ERK1/2抑制剂组的317±67(<0.01),空腺病毒+DMSO组细胞的管状结构总长度显著长于空腺病毒+ERK1/2抑制剂组的(13 188±2 306)μm(<0.01)。P311可通过激活VEGFR2/ERK1/2信号通路增强HMEC-1的血管生成能力。